Nautilus Biotechnolgy
NAUT
75 hedge funds and large institutions have $173M invested in Nautilus Biotechnolgy in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 7 closing their positions.
41% more capital invested
Capital invested by funds: $123M → $173M (+$50.2M)
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
15% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 20
3% more funds holding
Funds holding: 73 → 75 (+2)
0.24% more ownership
Funds ownership: 35.65% → 35.89% (+0.24%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
77% less call options, than puts
Call options by funds: $38K | Put options by funds: $163K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$873K |
| 2 |
State Street
Boston,
Massachusetts
|
+$639K |
| 3 |
ST
Sentinel Trust
Houston,
Texas
|
+$360K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$260K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$153K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tikvah Management
Charlotte,
North Carolina
|
-$504K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$431K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$176K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$158K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$110K |
NAUT Hedge Fund Activity: Q2 2023 in Review
75 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q2 2023, worth a combined $173M — up 41% from $123M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NAUT positions and 7 closed out — a net gain of 2 holders — while 23 added to existing stakes and 20 trimmed.
The largest buyer was BlackRock, adding an estimated $873K. The largest seller was Tikvah Management, cutting an estimated $504K.
- 75 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q2 2023, up from 73 in Q1 2023.
- Funds reported $173M of Nautilus Biotechnolgy stock for Q2 2023, up 41% quarter-over-quarter.
- 9 funds opened new Nautilus Biotechnolgy positions in Q2 2023 and 7 closed out, a net change of +2 holders.
- The largest Nautilus Biotechnolgy buyer in Q2 2023 was BlackRock, an estimated $873K added.
- The largest Nautilus Biotechnolgy seller in Q2 2023 was Tikvah Management, an estimated $504K sold.
Based on aggregated 13F filings for Q2 2023.